Module

Lymphomas and Hodgkin's Disease

Source: Lymphoma Annual Update 2005

Lymphomas and Hodgkin's Disease


Program Director: Julie M. Vose, MD

Faculty:

  • Frederick B. Hagemeister, MD

CME CREDIT INFORMATION

Release Date: 10/14/05

Expiration Date: 10/13/06


Physicians: maximum of 1 AMA PRA Category 1 Credit(s)™

Registered Nurses: 1.3 Nursing CE credits

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe strategies for management of relapsed Hodgkin's lymphoma, including treatment complications.

  • Evaluate efficacy and safety of currently available therapy for Hodgkin's lymphoma.

  • Review results of recent clinical trials for early-stage and advanced Hodgkin's lymphoma.


Topics covered include:

  • Introduction--Long-Term Treatment of Hodgkin's Lymphoma
  • Classification of Hodgkin's Lymphoma
  • Treatment of Early-Stage HL: ABVD Plus Radiation
  • Treatment of Early-Stage HL: Chemotherapy Alone
  • Classification of Early-Stage HL with Poor Prognostic Features
  • Treatment of Poor Prognosis Early-Stage HL
  • Prognostic Factors for Advanced HL
  • Treatment for Advanced HL
  • Radiation for Advanced HL
  • Treatment of Relapsed HL
  • Autologous Stem Cell Transplantation for Relapsed HL
  • Prognostic Factors for Autologous Stem Cell Transplantation
  • Novel Autologous Stem Cell Transplantation Programs
  • New Single or Combination Therapies for Relapsed HL
  • Complications of Therapy for HL
  • Summary Future Directions in HL
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grants provided by:

Educational grants support only the CME-certified components of this program.